AI scientist company Edison tapped by team behind Metsera to create biotechs
AI scientist company Edison tapped by team behind Metsera to create biotechs
Publish Date: 2026-06-29 00:31:00
Source Domain: www.statnews.com
- CEO Sam Rodriques of FutureHouse, an AI scientist company, experienced skepticism when top-tier pharmaceutical companies offered $30 million to use their AI agents for drug discovery, showcasing the high interest in AI within the industry.
- Rodriques and co-founder Andrew White founded FutureHouse in 2023 with the mission to enhance scientific discovery through autonomous AI agents but pivoted to a commercial product, Edison Scientific, after realizing the demand from big pharma.
- The interest from large pharmaceutical companies indicates a competitive landscape where companies are willing to invest heavily in advanced AI technologies for drug discovery.
- FutureHouse’s spin-off Edison Scientific, created in late 2025, secured $70 million in venture funding, highlighting the commercial viability and the substantial market potential for their innovative AI solutions.
